OTCMKTS:QPWR QSAM Biosciences (QPWR) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range$0.02▼$8.2552-Week Range N/AVolume437,200 shsAverage Volume68,770 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get QSAM Biosciences alerts: Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About QSAM Biosciences Stock (OTCMKTS:QPWR)QSAM Biosciences, Inc. is a holding company, which engages in the process and provision of renewable energy. Its product portfolio includes waste water treatment plants, landfills, and livestock farms. The company was founded by Christopher M. Nelson on August 26, 2004 and is headquartered in Palm Beach, FL.Read More Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here QPWR Stock News HeadlinesFebruary 16, 2024 | morningstar.comQSAM Biosciences Inc QSAMFebruary 8, 2024 | msn.comTelix to acquire QSAM Biosciences for $123.1mJuly 27, 2024 | Weiss Ratings (Ad)The next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.November 14, 2023 | msn.comQSAM Biosciences signs term sheet to be acquired by Telix PharmaceuticalsMay 17, 2023 | marketwatch.comInvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Inks Supply Agreement with Leading Nuclear Medicine Pharmacy NetworkMay 13, 2023 | marketwatch.com8-K: QSAM Biosciences, Inc.April 27, 2023 | marketwatch.comQSAM Biosciences Receives Second Key Patent in Europe for its Clinical Stage Radiopharmaceutical Drug Candidate, CycloSam(R)April 5, 2023 | marketwatch.comInvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Phase 1 CycloSam(R) Study Ready to Open Cohort 2 EnrollmentJuly 27, 2024 | Weiss Ratings (Ad)The next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.April 5, 2023 | marketwatch.comQSAM Biosciences Opens Enrollment of the Second Cohort of Patients in its Phase 1 Study of CycloSam(R) Targeting Metastatic Bone CancerMarch 8, 2023 | msn.comQSAM receives clearance from FDA to expand enrollment criteria for bone cancer treatmentFebruary 24, 2023 | benzinga.comInvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Adds New Trial Site to Expand Study of CycloSam(R) for Bone CancerFebruary 23, 2023 | finance.yahoo.comQSAM Biosciences, Inc. (QSAM) Stock Historical Prices & Data - Yahoo FinanceAugust 16, 2022 | finance.yahoo.comQSAM Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateMay 17, 2022 | finance.yahoo.comQSAM Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate UpdateSee More Headlines Receive QPWR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for QSAM Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Waste Management Sub-IndustryN/A Current SymbolOTCMKTS:QPWR CUSIPN/A CIK1310527 Webq2earth.com Phone(561) 693-1423FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDouglas R. BaumChief Executive Officer & DirectorChristopher M. NelsonPresident, Director & General CounselMike VogelSenior Vice President-OperationsWilliam KishVice President-Operations & Business DevelopmentNicole MayerControllerKey CompetitorsAgilyx ASAOTCMKTS:AGXXFBefesaOTC:BFSAFClean TeQOTCMKTS:CTEQFCleanaway Waste ManagementOTCMKTS:TSPCFDaiseki Co.,Ltd.OTCMKTS:DSKIFView All Competitors QPWR Stock Analysis - Frequently Asked Questions How do I buy shares of QSAM Biosciences? Shares of QPWR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of QSAM Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that QSAM Biosciences investors own include XOMA (XOMA), Morgan Stanley (MS), Cyclone Power Technologies (CYPW), Cameco (CCJ), Altisource Portfolio Solutions (ASPS). This page (OTCMKTS:QPWR) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QSAM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share QSAM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.